Ann: Quarterly Activities Report and Appendix 4C, page-25

First 25 Last

Share
Profile

Follow
Keith2

758 Posts.

39

10/12/21

14:47

Post #: 58216745
Share

Originally posted by Goneallin: ↑

In their recent presentation, on slide 10, under the heading S3 registration, the company states the following:

Bod will become one of the first companies to introduce a Schedule 3 (Pharmacist Only) CBD product in AustraliaFollows recent TGA decision allowing low dose CBD products to be sold over-the-counter by a pharmacist to consumers without a prescriptionUnlocks a market valued at an estimated $250m - unregulated market valued at ~$3.5Bn highlighting potential product demandBod has entered into an agreement with Australia’s leading research group the Woolcock Institute as the lead investigator of the trialCollaboration allows Bod to progress a phase IIb clinical trial to test the efficacy of its unique CBD Product on symptoms associated with sleeplessnessPatient recruitment expected to start in January 2022with the 12 week trial expected to commence February 2022Following completion of the trial and receipt of an ARTG registration through the TGA, Bod will commercialise the product(s) in collaboration with multiple partners.

can someone please clarify exactly what stage BOD is up to with registering a S3 product? My interpreting of what they have written here, is after the phase 2b trial they will be going ahead with registering their product for over the counter sales, which all things being equal they may be in a position to do by the end of CY22. It is my understanding that they will need to do an additional stage 3 trial which blows this timeframe out by at least a year. This has huge implications from an investing perspective! Considering the lack of engagement I got with my last question I will add this statement: If you folk (who are invested in BOD) can’t answer this question, then you aren’t worth the money you have invested, just blindly swinging in the hope you get lucky. Surely one of you have an answer to such an important and basic question?

Expand

why dont you e-mail bod and ask them that question..

BOD Price at posting: 24.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CC9

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

FEX

From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources

SXG

From the Floor question: "Could gold be manufactured in a lab like diamonds?"

Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars

AL8

From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources

There are more pages in this discussion • 2 more messages in this thread...

First 25 Last

Add BOD (ASX) to my watchlist

(20min delay)
Last 2.4¢		Change 0.000(0.00%)		Mkt cap ! $4.256M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Quarterly Activities Report and Appendix 4C, page-25

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources

From the Floor question: "Could gold be manufactured in a lab like diamonds?"

Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars

From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources

Featured News

Featured News

Ann: Quarterly Activities Report and Appendix 4C, page-25

Top Stories

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources

From the Floor question: "Could gold be manufactured in a lab like diamonds?"

Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars

From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources

Featured News

Featured News